Highly Effective mRNA-Based Malaria Vaccine to Undergo Clinical Trial by End of 2022, BioNTech Announces

Medicine & Technology Jul 27, 2021

BioNTech announces its plans on developing a highly effective mRNA-based malaria vaccine after the success of the mRNA COVID-19 vaccine that they co-developed with Pfizer. What could the public expect from this?

COVID-19 Vaccines: Almost 280,000 Lives Saved, Over a Million Hospitalizations Preempted in the US

Jul 09, 2021

New estimates from researchers recently showed that COVID-19 vaccines were able to save hundreds of thousands of lives and preempted over a million hospital admissions in the United States.

COVID-19 Vaccines: Mixing AstraZeneca and Pfizer Vaccines Gives Good Protection that Could Last for Years

Jun 29, 2021

A UK study found that mixing different brands of COVID-19 vaccines, specifically mRNA vaccines from AstraZeneca and Pfizer could give better protection that could last for several years.

COVID-19 Vaccines: Moderna, Pfizer Effective Against New India Variant, Research Finds

May 12, 2021

A new study recently found that the two current COVID-19 vaccines from Moderna and Pfizer are effective against the new India variant.

CDC Recommends Resumption of Use of Jonhnson & Johnson Vaccine After Investigating Rare Blood Clotting Incidents

Apr 23, 2021

The CDC has recommended resumption of the use of the Johnson & Johnson COVID-19 vaccine in the United States after the stoppage of immunizations to investigate reports of rare blood clots.

Chinese Vaccines "Don't Have Very High Protection Rates," Says China CDC Official

Apr 12, 2021

China CDC's director Gao Fu admitted that Chinese vaccines “don’t have very high protection rates.” They are now considering using different vaccines for their immunization program.

COVID-19 mRNA Vaccines Myths Debunked, Experts Weigh in 6 Important Facts

Feb 21, 2021

An immunologist and pharmacist reveal six important facts about COVID-19 mRNA vaccines, debunking some myths surrounding mRNA vaccine technology.